Zobrazeno 101 - 110
of 3 731
pro vyhledávání: ''
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
PurposeAs the aging of society progresses, the proportion of extremely older lung cancer patients has also increased; However, studies of these patients with non–small cell lung cancer are limited. Therefore, we investigated the initial treatment m
Autor:
Dorothea Miller, Sabine Seidel, Michelle Margold, Kirsten Schmieder, Thomas Kowalski, Uwe Schlegel, Seena Anton
Publikováno v:
Hematological Oncology. 39:176-184
The implantation of a subgaleal reservoir (ICV port) in order to apply intracerebroventricular (ICV) chemotherapy in patients with leptomeningeal cancer may be complicated by misplacement of the device, pericatheter leucencephalopathy, hemorrhage and
Autor:
Anke Bergmann, Marcelo Adeodato Bello, Luiz Claudio Santos Thuler, Isabella Cristina Santos Soares
Publikováno v:
Breast Cancer Research and Treatment. 187:547-555
Different tumor-related factors have been proposed to assess the risk of disease progression and death in women undergoing neoadjuvant breast cancer chemotherapy. Recently, besides the classical pre-treatment clinical stage (CS) and post-treatment pa
Autor:
Tatsuro Okamoto, Takashi Seto, Takatoshi Fujishita, Shinkichi Takamori, Mikako Jinnouchi, Mototsugu Shimokawa, Ryo Toyozawa, Masafumi Yamaguchi, Kensaku Ito, Taichi Matsubara
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:1857-1864
Pneumonitis can be triggered by anti-cancer therapies: cytotoxic chemotherapy, tyrosine kinase inhibitors, and immune checkpoint inhibitors. There are few treatment options for patients who develop such pneumonitis and their treatment including chemo
Autor:
James D. Luketich, Olugbenga T. Okusanya, Rajeev Dhupar, Chigozirim N. Ekeke, Chandler Mitchell, Matthew J. Schuchert
Publikováno v:
Clin Lung Cancer
Operable stage I non–small-cell lung cancer portends a positive prognosis. However, the descriptive characteristics of patients who have developed early distant recurrence have remained poorly defined. Most of these patients with early distant recu
Autor:
Alla Berlin, Leora Brazg Ferro, Ester Osher, Orit Gutfeld, Inbal Golomb, Inna Ospovat, Viacheslav Soyfer, Ido Wolf, Shira Peleg Hasson
Publikováno v:
Oncology. 99:373-379
Introduction: Extrapulmonary small-cell cancer (EPSCC) is a relatively rare malignancy. The management of EPSCC is usually extrapolated from small-cell lung cancer (SCLC). In spite of the morphological similarity of the 2 malignancies, there are many
Autor:
Thibault Marquette, Laure Doisy, S. Rybikowski, Aurélien Adypagavane, T. Maubon, Jochen Walz, Arnaud Cimier, Eric Lechevallier, Gwenaelle Gravis, Kevin Loverde, S. Fakhfakh, Dominique Rossi, Géraldine Pignot, Nicolas Mottet, Jacques Irani
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1633-1638 (2021)
Purpose To evaluate Hyperthermic-Intra-Vesical Chemotherapy (HIVEC) efficacy regarding 1-year disease-free survival (RFS) rate and bladder preservation rate in patients with High-risk Non-Muscle Invasive Bladder Cancer (NMIBC) who fail BCG therapy or
Autor:
Thomas J. Quinn, Craig W. Stevens, Andrew B. Thompson, Nikhil P. Mankuzhy, Thomas Guerrero, Zaid A. Siddiqui, K.C. Lee, Inga S. Grills, Muayad F. Almahariq
Publikováno v:
Clinical Lung Cancer. 22:e5-e17
Background The role for postoperative radiation therapy (PORT) for patients with non–small-cell lung cancer (NSCLC) with mediastinal lymph node (LN) involvement (pN2 disease) is controversial. We compared surgery alone with PORT among patients with
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background We evaluated the prognostic potential of tumor 18F-fluorodeoxyglucose (FDG) uptake derived from positron emission tomography (PET) and known inflammatory hematological markers, both individually and in combination, for chemosensitivity and
Autor:
Bao-Cai Xing, Da Xu, Ying-Shi Sun, Meng Ye, Xiao-Yan Zhang, Hai-Bin Zhu, Li Sun, Pei Nie, Xiao-Ting Li
Publikováno v:
International Journal of Cancer. 148:1717-1730
Accurate evaluation of tumor response to preoperative chemotherapy is crucial for assigning appropriate patients with colorectal liver metastases (CRLM) to surgery or conservative therapy. However, there is no well-recognized method for predicting pa